The Brighterside of News on MSN
First human trial of a CRISPR-based treatment significantly lowered cholesterol and ...
A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...
Barchart on MSN
Should You Buy the Dip in Intellia Therapeutics Stock?
A patient’s death shook Intellia Therapeutics and sank its stock. Should investors buy the dip or steer clear?
The Epidermolysis Bullosa (EB) market is evolving dynamically due to increased disease awareness and advances in genetic research. EB is a genetic disorder that causes skin fragility and severe ...
In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates ...
Origin Agritech is a Chinese company focused on developing and selling genetically modified (GM) seeds, especially for corn.
This study provides valuable data on the role of Hsd17b7, a gene involved in cholesterol biosynthesis, as a potential regulator of mechanosensory hair cell function. The authors used both zebrafish ...
With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum ...
Osteoarthritis (OA) is the most common degenerative joint disease worldwide, leading to significant health and socioeconomic ...
The Korean Academy of Medical Sciences and Boehringer Ingelheim Korea announced on November 12 that Doyeon Oh, Professor of ...
WHEAT RIDGE, CO / ACCESS Newswire / November 12, 2025 / Lifeloc Technologies, Inc. , a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced ...
Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果